HK1252798A1 - Composition for nebulizers - Google Patents
Composition for nebulizersInfo
- Publication number
- HK1252798A1 HK1252798A1 HK18112099.5A HK18112099A HK1252798A1 HK 1252798 A1 HK1252798 A1 HK 1252798A1 HK 18112099 A HK18112099 A HK 18112099A HK 1252798 A1 HK1252798 A1 HK 1252798A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nebulizers
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015154754 | 2015-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1252798A1 true HK1252798A1 (en) | 2019-06-06 |
Family
ID=57943114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18112099.5A HK1252798A1 (en) | 2015-08-05 | 2018-09-20 | Composition for nebulizers |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP6908523B2 (en) |
KR (1) | KR20180030399A (en) |
CN (1) | CN107847482A (en) |
HK (1) | HK1252798A1 (en) |
TW (1) | TWI762449B (en) |
WO (1) | WO2017022814A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109771398B (en) * | 2019-02-25 | 2019-09-20 | 广州南鑫药业有限公司 | A kind of Peramivir solution-type inhalant and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001252578A1 (en) * | 2000-04-25 | 2001-11-07 | Sankyo Company Limited | Preventives for influenza |
GB0014869D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
RU2279292C2 (en) * | 2001-10-24 | 2006-07-10 | Пари Гмбх | Set for pharmaceutical composition preparing |
PE20050941A1 (en) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | AQUEOUS CYCLESOUND SUSPENSIONS FOR MISTING |
ITMI20051999A1 (en) * | 2005-10-21 | 2007-04-22 | Eratech S R L | INHALATION FORMULATIONS OF DRUGS IN DRY POWDER FOR ADMINISTRATION AS SUCH OR WITH NEBULIZER AND EQUIPPED WITH HIGH EROGABILITY RESPIRABILITY AND STABILITY |
US20080000473A1 (en) * | 2005-12-29 | 2008-01-03 | Hugo Stephenson | pH-Based Methods and Devices for Preventing Hemagglutinin Cell Membrane Fusion |
US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
GB0806873D0 (en) * | 2008-04-16 | 2008-05-21 | Breath Ltd | Steroid nebuliser formulation |
TWI491416B (en) * | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | A dry powder pharmaceutical composition for inhalation |
CN101773491A (en) * | 2010-03-23 | 2010-07-14 | 江苏先声药物研究有限公司 | Zanamivir inhalation solution and application thereof |
-
2016
- 2016-08-04 CN CN201680045861.9A patent/CN107847482A/en active Pending
- 2016-08-04 JP JP2017533115A patent/JP6908523B2/en active Active
- 2016-08-04 WO PCT/JP2016/072885 patent/WO2017022814A1/en active Application Filing
- 2016-08-04 KR KR1020177029766A patent/KR20180030399A/en not_active Application Discontinuation
- 2016-08-05 TW TW105124890A patent/TWI762449B/en active
-
2018
- 2018-09-20 HK HK18112099.5A patent/HK1252798A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20180030399A (en) | 2018-03-22 |
TWI762449B (en) | 2022-05-01 |
JP6908523B2 (en) | 2021-07-28 |
TW201717936A (en) | 2017-06-01 |
CN107847482A (en) | 2018-03-27 |
WO2017022814A1 (en) | 2017-02-09 |
JPWO2017022814A1 (en) | 2018-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201512030D0 (en) | Composition | |
GB201521507D0 (en) | Composition | |
GB201505527D0 (en) | Composition | |
GB201506827D0 (en) | Composition | |
PL3182957T3 (en) | Cineole-containing composition for nasal application | |
HK1250339A1 (en) | Composition | |
PL3344702T3 (en) | Composition | |
GB201506829D0 (en) | Composition | |
GB201506830D0 (en) | Composition | |
GB2545773B (en) | Composition | |
GB201522603D0 (en) | Composition | |
GB201519327D0 (en) | Composition | |
GB201506828D0 (en) | Composition | |
GB201504665D0 (en) | Composition | |
GB201504307D0 (en) | Composition | |
GB201522681D0 (en) | Composition | |
GB201518348D0 (en) | Composition | |
GB201515639D0 (en) | Composition | |
GB201514585D0 (en) | Composition | |
GB201511697D0 (en) | Composition | |
GB201509044D0 (en) | Composition | |
GB201505520D0 (en) | Composition | |
HK1252798A1 (en) | Composition for nebulizers | |
GB201508722D0 (en) | Composition | |
GB201506826D0 (en) | Composition |